Rapid immunochromatographic test for the qualitative detection of dermatophyte antigen, that is, the defense substances formed by the body as a result of the immune reaction, in nails (diagnostic aid for Tinea unguium).
Immunological rapid testfor the qualitative detection of antibodies that have been raised against H. pylori from capillary blood, venous blood, serum or plasma. Antibodies are detectable in the patient's blood during and after an acute infection.
Immunological rapid test for the qualitative detection of Influenza virus antigen A and B from nose and throat swabs. The test detects different influenza A subtypes, including the H3N2 and H1N1 subtypes.
Immunological rapid test for the qualitative detection of human antibodies of the classes IgM, IgG and IgA against pathogens of the Mycobacterium tuberculosis complex (M. tuberculosis, M. bovis und M. africanum) in whole blood. It detects both early and late stages of the infection.
Immunological rapid test for the specific detection of human hemoglobin in faeces. The test shows positive results with hemoglobin higher than 50 ng/mL. The specifi city of the test is not influenced by interfering substances in food or medications.
Immunological rapid test for the detection of human occult blood in faeces. The test detects haemoglobin as well as the haemoglobin/haptoglobin complex. The combination of both parameters increases the likelihood of fi nding bleeding polyps and adenomas in the upper intestinal tract. Analytical sensitivity: 50 ng/mL.
Immunological rapid test for the determination of faecal calprotectin for diagnosis and therapy monitoring of intestinal inflammations. The test has two cut-offs at 50 µg/g and 200 µg calprotectin/g stool. A faecal calprotectin concentration above 200 µg/g in drug treated IBD patients indicates a relapse.
Immunological rapid test for the detection of calprotectin in faeces. The use of this test with a single cut-off at 50 µg calprotectin/g stool enables rapid routine-screening of patients with chronic intestinal problems and enables the diff erentiation of infl ammatory (≥50 µg/g) and non-infl ammatory (<50 µg/g) intestinal diseases.